(Q34742866)

4 August 2017

1 reference

title

The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent (English)

1 reference

4 August 2017

1 reference

Greenway FL

1

1 reference

4 August 2017

1 August 2001

1 reference

4 August 2017

1 reference

4 August 2017

2

1 reference

4 August 2017

3

1 reference

4 August 2017

199-211

1 reference

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Caffeine disposition in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Snoring and breathing pauses during sleep: telephone interview survey of a United Kingdom population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Habitual coffee consumption and blood pressure: A study of self-defense officials in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Ephedrine reduces weight of viable yellow obese mice (Avy/a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Combined drug treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Pharmaceutical cost savings of treating obesity with weight loss medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Ephedrine-induced thermogenesis as an adjunct to cognitive restructuring and covert conditioning: a proposal for treatment of obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Food intake, energy balance and body weight control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Present and future pharmacological approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Current and potential drugs for treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Drug treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Pharmacological and clinical studies of ephedrine and other thermogenic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2001.00038.X

10.1046/J.1467-789X.2001.00038.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12120105